CareDx Q4 Revenue Climbs 25% to $108.4M While EPS Misses Estimates
CareDx’s Q4 revenue rose 25.2% year-over-year to $108.39 million, beating estimates by 5.66%, while EPS declined to $0.12 versus the $0.24 consensus and $0.18 a year ago. Patient and digital solutions revenue jumped 47.1% to $16.76 million, testing services revenue grew 22.8% to $78.37 million.
1. Q4 Financial Results
CareDx reported Q4 revenue of $108.39 million, up 25.2% year-over-year, surpassing consensus by 5.66%, while EPS was $0.12, missing the $0.24 forecast by 48.94% and down from $0.18 a year ago.
2. Segment Revenue Breakdown
Patient and digital solutions revenue reached $16.76 million, up 47.1% against estimates of $15.25 million; testing services revenue was $78.37 million, rising 22.8% versus the $74.95 million forecast; and product revenue grew 16.6% to $13.26 million, above the $12.45 million consensus.
3. Stock Reaction and Outlook
Shares have edged down 0.3% year-to-date versus the S&P 500’s 0.1% decline, and the stock holds a Zacks Rank #3 (Hold). Analysts project next quarter EPS of $0.18 on $100.37 million revenue and full-year EPS of $0.77 on $417.35 million.